Laboratory techniques

Movement Industries Corporation (OTC: MVNT) Releases Details on its New Process Solutions Division  

Thursday, November 21, 2019 - 6:22pm

Houston, TX, Nov. 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Movement Industries Corporation (OTC PINK: MVNT) (Movement), formerly Visual Healthcare Corp, today announced preliminary details on its new process solutions division.

Key Points: 
  • Houston, TX, Nov. 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Movement Industries Corporation (OTC PINK: MVNT) (Movement), formerly Visual Healthcare Corp, today announced preliminary details on its new process solutions division.
  • The process solutions division will provide engineering, manufacturing, fabrication and installation for mass transfer equipment such as trays, packing, distributors and ancillary hardware for the refining and petrochemical industries, as well as distillation and extraction units for the agriculture industry.
  • The company expects its new division to begin generating revenues early in the first quarter of 2020.
  • Movement, formerly Visual Healthcare Corp., invests in emerging growth companies in energy, oil & gas, renewables and industrial manufacturing sectors.

United States Digital PCR (dPCR) and Real Time PCR (qPCR) Market to 2025 - ResearchAndMarkets.com

Friday, November 15, 2019 - 2:41pm

The country research report on the United States digital PCR (dPCR) and real time PCR (qPCR) market is a customer intelligence and competitive study of the United States market.

Key Points: 
  • The country research report on the United States digital PCR (dPCR) and real time PCR (qPCR) market is a customer intelligence and competitive study of the United States market.
  • The report on the United States digital PCR (dPCR) and real time PCR (qPCR) market provides a detailed analysis of segments in the market based on product type, and application.
  • 3) What is the competitive position in the United States digital PCR (dPCR) and real time PCR (qPCR) market?
  • 5) What are the modes of entering the United States digital PCR (dPCR) and real time PCR (qPCR) market?

Global $1.04 Bn Fluorescent in Situ Hybridization (FISH) Probe Market to 2026 by Technology (Q FISH, FLOW FISH), Type (DNA, RNA), Application (Cancer Research, Genetic Diseases)

Thursday, November 14, 2019 - 3:15pm

The global fluorescent in situ hybridization (fish) probe market size is expected to reach USD 1.04 billion by 2026, according to this report.

Key Points: 
  • The global fluorescent in situ hybridization (fish) probe market size is expected to reach USD 1.04 billion by 2026, according to this report.
  • Increasing global population prone to target diseases and demand for accurate and effective diagnostics of these diseases are the factors attributed to the growth.
  • Increasing use of FISH probes in vitro diagnosis of various infectious diseases is expected to create growth opportunities in near future.
  • Further key findings from the study suggest:
    Companion diagnostics is expected to command the largest market share of end use segment.

Fluidigm to Participate in the 31st Annual Piper Jaffray Healthcare Conference

Wednesday, November 13, 2019 - 9:05pm

SOUTH SAN FRANCISCO, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the companys management will participate in the 31st Annual Piper Jaffray Healthcare Conference in New York.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the companys management will participate in the 31st Annual Piper Jaffray Healthcare Conference in New York.
  • Chris Linthwaite, President and Chief Executive Officer, will participate in a fireside chat at the conference on Wednesday, December 4, 2019, at 1:30 pm ET.
  • A live webcast and subsequent replay will be available in the Events & Presentations section of the Fluidigm investor website.
  • Fluidigm, the Fluidigm logo and CyTOF are trademarks and/or registered trademarks of Fluidigm Corporation in the United States and/or other countries.

Global Fluorescent in Situ Hybridization (FISH) Probe Market Size, Share & Trends Analysis Report 2019-2026 - ResearchAndMarkets.com

Wednesday, November 13, 2019 - 2:32pm

The "FISH Probe Market Size, Share & Trends Analysis Report By Technology (Q FISH, FLOW FISH), By Type (DNA, RNA), By Application (Cancer Research, Genetic Diseases), By End Use, And Segment Forecasts, 2019 - 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "FISH Probe Market Size, Share & Trends Analysis Report By Technology (Q FISH, FLOW FISH), By Type (DNA, RNA), By Application (Cancer Research, Genetic Diseases), By End Use, And Segment Forecasts, 2019 - 2026" report has been added to ResearchAndMarkets.com's offering.
  • The global fluorescent in situ hybridization (fish) probe market size is expected to reach USD 1.04 billion by 2026, according to this report.
  • Increasing global population prone to target diseases and demand for accurate and effective diagnostics of these diseases are the factors attributed to the growth.
  • Further key findings from the study suggest:
    Companion diagnostics is expected to command the largest market share of end use segment.

Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering

Wednesday, November 13, 2019 - 2:20pm

Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the Company) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic research, today announced the pricing of an underwritten public offering of 2,285,000 shares of its common stock and warrants to purchase up to an aggregate of 2,285,000 shares of common stock.

Key Points: 
  • Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the Company) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic research, today announced the pricing of an underwritten public offering of 2,285,000 shares of its common stock and warrants to purchase up to an aggregate of 2,285,000 shares of common stock.
  • Gross proceeds, before underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $12.0 million, not including any amounts received upon exercise of the warrants.
  • The shares of common stock and the accompanying warrants, can only be purchased together in the offering, but will be issued separately.
  • The offering is expected to close on or about November 15, 2019, subject to customary closing conditions.

Global $14+ Billion In-Vitro Toxicology/Toxicity Testing Market by Product & Service, Technology, Method, End-point, End-user & Geography - Forecast to 2025 - ResearchAndMarkets.com

Tuesday, November 12, 2019 - 5:39pm

The global in-vitro toxicology testing market is expected to grow at a CAGR of 9% from 2019 to reach $14.4 billion by 2025.

Key Points: 
  • The global in-vitro toxicology testing market is expected to grow at a CAGR of 9% from 2019 to reach $14.4 billion by 2025.
  • How is the competitive landscape and who are the market leaders in the global in vitro toxicology testing market?
  • What are the different strategies adopted by the major players in the global in vitro toxicology testing market?
  • Who are the local emerging players in the global in vitro toxicology testing market and how do they compete with the global players?

Successful DNA Tagging of Leather at One of the World’s Largest Tanneries

Tuesday, November 12, 2019 - 2:03pm

Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA, we, our or the Company), a leader in large-scale Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the successful DNA tagging of leather at one of the worlds largest tanneries based in Asia.

Key Points: 
  • Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA, we, our or the Company), a leader in large-scale Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the successful DNA tagging of leather at one of the worlds largest tanneries based in Asia.
  • Further work in commercial tanneries by the Applied DNA UK team took place following the research project in other tanneries to identify the most practical ways to use SigNature DNA technology in the leather supply chain.
  • We are pleased by the interest shown across the leather industry in offering to leather supply chains.
  • Applied DNA has developed its CertainT system for marking leather through the leather value chain by using a DNA tag.

Thermo Fisher Scientific Unveils Metrios AX - a Machine Learning S/TEM

Tuesday, November 12, 2019 - 1:00pm

PORTLAND, Ore., Nov. 12, 2019 /PRNewswire/ -- Thermo Fisher Scientific, today at the International Symposium for Testing and Failure Analysis (ISTFA) 2019, announced the Thermo Scientific Metrios AX, the world's first commercially released scanning transmission electron microscope (S/TEM) to use machine learning to automate high-quality data collection.

Key Points: 
  • PORTLAND, Ore., Nov. 12, 2019 /PRNewswire/ -- Thermo Fisher Scientific, today at the International Symposium for Testing and Failure Analysis (ISTFA) 2019, announced the Thermo Scientific Metrios AX, the world's first commercially released scanning transmission electron microscope (S/TEM) to use machine learning to automate high-quality data collection.
  • The Metrios AX enables semiconductor labs to automatically acquire and measure critical dimensions on semiconductor devices during development or in support of manufacturing.
  • Incorporating machine learning into the instrument helps minimize the time needed to develop automated recipes, allowing more productive utilization of the microscope.
  • Thermo Fisher Scientific is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally.

North America & European Protein Electrophoresis Analysis Report 2019

Monday, November 11, 2019 - 10:45am

DUBLIN, Nov. 11, 2019 /PRNewswire/ -- The "2019 Protein Electrophoresis and Western Analysis Dashboard Series 4 - NA & EU" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 11, 2019 /PRNewswire/ -- The "2019 Protein Electrophoresis and Western Analysis Dashboard Series 4 - NA & EU" report has been added to ResearchAndMarkets.com's offering.
  • Protein electrophoresis is a commonly used technique to separate proteins and is often followed by in-gel staining and/or western analysis to detect the proteins of interest.
  • With a wide variety of applications in proteomics, ranging from protein characterization to protein quantification and applications in other areas such as clinical diagnostics and verification of in vivo and in vitro protein expression, protein electrophoresis and western analysis products are widely used by scientists in academia and industry.
  • The 2019 Protein Electrophoresis and Western Analysis Dashboard were developed from responses to a 46-question survey completed by 496 scientists located in North America and Europe.